August 2023 FAQs
- What literature supports the use of low-dose rifaximin in patients with hepatic encephalopathy?
- What data exists on the use of buprenorphine and buprenorphine-naloxone for the treatment of kratom withdrawal?
- Is there a preference between topical natamycin and topical voriconazole for first-line treatment of fungal keratitis?